Alphatec/ATEC

$13.30

-3.48%
-
1D1W1MYTD1YMAX

About Alphatec

Alphatec Holdings, Inc., through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A.S. and SafeOp Surgical, Inc., is a medical device company. The Company is focused on the design, development, and advancement of technology for surgical treatment of spine disorders. It has a range of product portfolios designed to address the spine's various pathologies. Its AIX product platform comprises of its EOS imaging system and VEA alignment mobile application, its SafeOp Neural InformatiX System and Valence. The EOS imaging system is designed to provide calibrated full-body imaging that enables a three-dimensional (3D) model of patients’ skeletal systems. It has developed a patient positioning systems that integrates with its other access systems, providing for a more rigid construct and enhanced reproducibility. It offers procedure-specific access systems, including its Sigma-ALIF Access System, which allows for custom anterior abdominal exposure.

Ticker

ATEC

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Patrick Miles

Employees

839

Headquarters

Carlsbad, United States

Alphatec Metrics

BasicAdvanced
$1.84B
Market cap
-
P/E ratio
-$1.54
EPS
1.47
Beta
-
Dividend rate
$1.84B
1.46762
$19.14
$8.66
1.65M
2.863
1.994
502.399
504.176
-5.4%
-28.15%
-859.11%
-36.25%
3.805
23.708
37.45%
-8.86%
49.32%

What the Analysts think about Alphatec

Analyst Ratings

Majority rating from 11 analysts.
Buy

Price Targets

Average projection from 11 analysts.
76.02% upside
High $32.00
Low $19.00
$13.30
Current price
$23.41
Average price target

Alphatec Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-35.53% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$137.9M
16.67%
Net income
$-49M
15.02%
Profit margin
-35.53%
-1.42%

Alphatec Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 47.08%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.40
-$0.43
-$0.35
-$0.37
-
Expected
-$0.31
-$0.28
-$0.28
-$0.25
-$0.31
Surprise
27.21%
52.33%
23.92%
47.08%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Alphatec stock?

Alphatec (ATEC) has a market cap of $1.84B as of April 14, 2024.

What is the P/E ratio for Alphatec stock?

The price to earnings (P/E) ratio for Alphatec (ATEC) stock is 0 as of April 14, 2024.

Does Alphatec stock pay dividends?

No, Alphatec (ATEC) stock does not pay dividends to its shareholders as of April 14, 2024.

When is the next Alphatec dividend payment date?

Alphatec (ATEC) stock does not pay dividends to its shareholders.

What is the beta indicator for Alphatec?

Alphatec (ATEC) has a beta rating of 1.47. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Alphatec stock price target?

The target price for Alphatec (ATEC) stock is $23.41, which is 76.02% above the current price of $13.3. This is an average based on projections from 11 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Alphatec stock

Buy or sell Alphatec stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing